Reproductive Endocrine and Endometrial Effects of Raloxifene Hydrochloride, a Selective Estrogen Receptor Modulator, in Women with Regular Menstrual Cycles

Chronic pelvic pain and endometriosis: translational evidence of the relationship and implications

Stratton, P., & Berkley, K. J. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmq050 · Cited by 442

Raloxifene- and estradiol-mediated effects on uterus, bone and B lymphocytes in mice

Erlandsson, M. C., Jonsson, C. A., Lindberg, M., Ohlsson, C., & Carlsten, H. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1750319 · Cited by 165

American Society of Clinical Oncology Technology Assessment on Breast Cancer Risk Reduction Strategies: Tamoxifen and Raloxifene

Chlebowski, R. T., Collyar, D. E., Somerfield, M. R., & Pfister, D. G. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.6.1939 · Cited by 163

Growth Hormone Binding Protein 2001

Baumann, G. (2001) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2001.14.4.355 · Cited by 139

Selective estrogen-receptor modulators for primary prevention of breast cancer.

Fabian, C., & Kimler, B. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.11.005 · Cited by 111

Selective estrogen receptor modulators (SERMs) for the brain: Current status and remaining challenges for developing NeuroSERMs

Zhao, L., O’Neill, K. E., & Brinton, R. D. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2005.01.009 · Cited by 120

Impact of the selective estrogen receptor modulator, raloxifene, on neuronal survival and outgrowth following toxic insults associated with aging and Alzheimer's disease.

O'Neill, K. I., Chen, S.-H., & Brinton, R. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2003.09.005 · Cited by 90

Genistein causes regression of endometriotic implants in the rat model

Yavuz, E., Öktem, M., Esinler, İ., Toru, H. S., & Zeyneloğlu, H. B. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.01.010 · Cited by 76

The 2.0 Å crystal structure of the ERα ligand‐binding domain complexed with lasofoxifene

Vajdos, F. F., Hoth, L. R., Geoghegan, K. F., et al. (2007) · Protein Science · doi:10.1110/ps.062729207 · Cited by 60

From Adjuvant Therapy to Breast Cancer Prevention: BCPT and STAR

Dunn, B. K., & Ford, L. G. (2001) · The Breast Journal · doi:10.1046/j.1524-4741.2001.007003144.x · Cited by 57

A New Selective Estrogen Receptor Modulator with Potent Uterine Antagonist Activity, Agonist Activity in Bone, and Minimal Ovarian Stimulation

Geiser, A. G., Hummel, C. W., Draper, M. W., Henck, J. W., COHEN, I. R., Rudmann, D. G., Donnelly, K. B., Adrian, M. D., Shepherd, T. A., Wallace, O. B., et al. (2005) · Endocrinology · doi:10.1210/en.2005-0024 · Cited by 53

Cardiovascular Effects of Raloxifene Hydrochloride

Saitta, A., Morabito, N., Frisina, N., Cucinotte, D., Corrado, F., D’Anna, R., Altavilla, D., Squadrito, G., Minutoli, L., Arcoraci, V., et al. (2001) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2001.tb00183.x · Cited by 48

Hormone replacement therapy: the perspectives for the 21st century

Genazzani, A. R., & Gambacciani, M. (1999) · Maturitas · doi:10.1016/s0378-5122(98)00109-1 · Cited by 48

Selective Estrogen Receptor Modulators in Reproductive Medicine and Biology

Baker, V. L., Leitman, D. C., & Jaffe, R. B. (2000) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-200007001-00001 · Cited by 46

Tamoxifen Treatment of Progressive Precocious Puberty in a Patient with McCune-Albright Syndrome

Eugster, E. A., Shankar, R. R., Feezle, L. K. S.-D., & Pescovitz, O. H. (1999) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.1999.12.5.681 · Cited by 43

Capitalizing on the Complexities of Estrogen Receptor Pharmacology in the Quest for the Perfect SERM

McDonnell, D. P., Chang, C., & Norris, J. D. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03999.x · Cited by 43

Options for Medical Treatment of Myomas

Rackow, B. W., & Arici, A. M. (2006) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2005.12.014 · Cited by 33

Endocrine disruption mechanism of o,p′-DDT in mature male tilapia (Oreochromis niloticus)

Leaños-Castañeda, O., Kraak, G. V. D., Rodríguez‐Canul, R., & Gold, G. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.03.011 · Cited by 31

Effects of Raloxifene on Circulating Prolactin and Estradiol Levels in Premenopausal Women at High Risk for Developing Breast Cancer

Faupel‐Badger, J. M., Prindiville, S. A., Venzon, D. J., et al. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0898 · Cited by 25

Gynecologic and hormonal effects of raloxifene in premenopausal women

Premkumar, A., Venzon, D. J., Avila, N. A., Johnson, D. V., Remaley, A. T., Forman, M. R., Eng‐Wong, J., Zujewski, J. A., & Stratton, P. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.01.095 · Cited by 23

The Effect of Selective Estrogen Receptor Modulators on Parameters of the Hypothalamic‐Pituitary‐Gonadal Axis

Plouffe, L., & Siddhanti, S. R. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb04029.x · Cited by 22

Effects of tamoxifen and raloxifene on normal human endometrial cells in an organotypic in vitro model

Bläuer, M., Heinonen, P. K., Rovio, P. H., et al. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.06.091 · Cited by 18

The Effect of Short-Term Treatment With Micronized Estradiol on Bone Turnover and Gonadotrophins in Older Men

Taxel, P., Kennedy, D., FALL, P. M., Willard, A. K., Shoukri, K., Clive, J. M., & Raisz, L. G. (2000) · Endocrine Research · doi:10.3109/07435800009066175 · Cited by 15

Luteinizing hormone secretion elicited in a ligand-independent activation of progesterone receptor manner at pituitary level in the rat: differential effect of two selective estrogen receptor modulators

Gónzalez, D., Bellido, C., Aguilar, R., et al. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01270-2 · Cited by 16

Selective estrogen receptor modulators (SERM) for the brain: Recent advances and remaining challenges for developing a NeuroSERM™

Brinton, R. (2002) · Drug Development Research · doi:10.1002/ddr.10090 · Cited by 14

Selective estrogen receptor modulators (SERMs) and retinoids in breast cancer chemoprevention

Zujewski, J. A. (2002) · Environmental and Molecular Mutagenesis · doi:10.1002/em.10054 · Cited by 13

Selective estrogen receptor modulators: the ideal estrogen replacement?

Sexton, M. J., & Gherman, R. B. (2001) · Primary Care Update for OB/GYNS · doi:10.1016/s1068-607x(00)00066-4 · Cited by 11

Hormone replacement therapy and the breast

Dixon, J. M. (2003) · Surgical Oncology · doi:10.1016/j.suronc.2003.10.001 · Cited by 11

Selective Estrogen Receptor Modulators: from Bench to Bedside and Back

WHITAKER, M. D. (2001) · Endocrine Practice · doi:10.4158/ep.7.2.113 · Cited by 9

McCune-Albright Syndrome Associated with Pituitary Microadenoma: Patient Report

Chen, C., Liu, J.-Y., Cheng, S.-N., et al. (2004) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2004.17.3.365 · Cited by 8

Effects of clomiphene and raloxifene on gonadotrophin secretion in postmenopausal women: evidence of nongenomic action

Garas, A., Trypsianis, G. A., Kallitsaris, A., et al. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02093.x · Cited by 7

Effect of raloxifene on salivary sex steroid concentrations in premenopausal women

Chatterton, R. T., Zujewski, J., Mateo, E. T., Eng‐Wong, J., & Jordan, V. C. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06791 · Cited by 7

Molecular and Clinical Evidence for the Unique Nature of Individual Selective Estrogen Receptor Modulators

Draper, M. W., & Chin, W. W. (2003) · Clinical Obstetrics & Gynecology · doi:10.1097/00003081-200306000-00008 · Cited by 6

Regulation of synaptic plasticity by hippocampus synthesized estradiol

Barron, A., Hojo, Y., Mukai, H., Higo, S., Ooishi, Y., Hatanaka, Y., Ogiue-Ikeda, M., Murakami, G., Kimoto, T., & Kawato, S. (2011) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci.2011.118 · Cited by 2

Drugs and Pituitary Function

Carlson, H. E. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-380926-1.10013-6 · Cited by 2

Effects of Progesterone and 17β-Estradiol under Presence or Absence of FBS on Plasminogen Activators Activity in Porcine Uterine Epithelial Cells

Hwangbo, Y., Lee, M.-R., Cheong, H.-T., et al. (2018) · Development & Reproduction · doi:10.12717/dr.2018.22.4.309 · Cited by 2

Effect of Three Dimensional Culture of Porcine Endometrial Cells on Their Plasminogen Activity and Pre-implantation Embryo Development after Co-culture

Lee, S., Hwangbo, Y., Cha, H.-J., et al. (2014) · Journal of Animal Reproduciton and Biotechnology · doi:10.12750/jet.2014.29.2.207 · Cited by 1

Breast-Cancer Prevention with Antiestrogens

Morrow, M., & Jordan, V. C. (2009) · Humana Press eBooks · doi:10.1007/978-1-59259-152-7_10 · Cited by 1

Comparative Study of Tamoxifen and Raloxifene on Endometrial Cell Proliferation of Female Rats in Persistent Estrus

Rodrigues‐Junior, D. M., dos Santos, A. R., Lopes‐Costa, P. V., et al. (2011) · International Journal of Gynecological Cancer · doi:10.1097/igc.0b013e31822d2c63 · Cited by 1

Neuroendocrine Aspects of Endometriosis‐Associated Pain

Stratton, P., & Berkley, K. J. (2011) · Wiley eBooks · doi:10.1002/9781444398519.ch22

SERMs’ Effect on the Neuroendocrine System and the Reproductive Organs

Santoro, N. F., & Kovács, P. (2002) · Humana Press eBooks · doi:10.1007/978-1-59259-157-2_10

Antiestrogens

Harper, M. J. K. (2002) · CRC Press eBooks · doi:10.3109/9780203219034-40

Growth Inhibition of Human Uterine Leiomyoma Cells by Selective Estrogen Receptor Modulator

Lee, M. Y., Cho, C., Kwon, S. H., et al. (2004) · Obstetrics & Gynecology Science

Raloxifene: A Selective Estrogen Receptor Modulator (SERM) with Multiple Target System Effects

Muchmore, D. B. (2000) · The Oncologist · doi:10.1634/theoncologist.5-5-388 · Cited by 133

[Evidence for the selective estrogen receptor modulator raloxifene: its evolving role in the treatment of osteoporosis].

Ohta, H. (2008) · PubMed · Cited by 1

[Clinical experience with raloxifene].

Szũcs, J., Pavo, I. J., & Jurida, N. (2000) · PubMed · Cited by 1

In Search of Optimal Long-Term Female Hormone Replacement: The Potential of Selective Estrogen Receptor Modulators

Mitlak, B., & Cohen, F. J. (2008) · Hormone Research · doi:10.1159/000185507 · Cited by 130